News & Events

Recent press releases

QuidelOrtho To Report First Quarter 2024 Financial Results

Learn more

QuidelOrtho Adds Fentanyl Test to Its Vitros^® Systems as a MicroTip^® Partnership Assay

Learn more

QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue^® COVID-19 Test

Learn more

All news

Legal Notice

By accessing, browsing, and/or using this website, you acknowledge that you have read, understood, and agree to be bound by QuidelOrtho’s Website Terms of Use, Privacy Notice and to comply with all applicable laws and regulations. If you do not agree to these terms, do not use the website. Additionally, the website contains information on products that is targeted to many different audiences and could contain product details or information otherwise not accessible or valid in your country. Product availability may vary from country to country and is subject to varying regulatory requirements. New QuidelOrtho branding may not be available in all markets, subject to country specific regulatory approval. Please be aware that we do not take any responsibility for your accessing such information that may not comply with any legal process, regulation, registration, or usage in the country of your origin.

QuidelOrtho Corporation
9975 Summers Ridge Road, San Diego, CA 92121, USA

Recent press releases

QuidelOrtho To Report First Quarter 2024 Financial Results

QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay

QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test

QuidelOrtho Adds Fentanyl Test to Its Vitros^® Systems as a MicroTip^® Partnership Assay

QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue^® COVID-19 Test